4//SEC Filing
Modig Berndt 4
Accession 0001636050-21-000047
CIK 0001636050other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:54 PM ET
Size
9.9 KB
Accession
0001636050-21-000047
Insider Transaction Report
Form 4
Modig Berndt
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-04-15+42,000→ 42,000 totalExercise: $2.47Exp: 2031-04-14→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]100% of this option will vest on April 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan.
Issuer
Sio Gene Therapies Inc.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001643072
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:54 PM ET
- Size
- 9.9 KB